Will a CRISPR-based therapy cure a major genetic disease by 2029?
CRISPR gene editing has advanced rapidly for treating diseases like sickle cell. This market asks whether a CRISPR or similar gene-editing therapy receives full approval and demonstrates a functional cure for a major inh...
Liquidity factor (b) | 100.00 |
Total liquidity | ℂ0.00 |
Volume | ℂ0.00 |
Open interest | 0 |
Share ratio | 0 / 0 |
The market resolves to YES if at least one CRISPR therapy is approved and shows long-term curative results for a major genetic disease by Dec 31, 2029, per FDA, EMA, or peer-reviewed studies. Resolves to NO otherwise.
No field changes found.
Probability history
Not enough data to display the chart.
Recent activity
No trades found.
Largest YES holders
No holders found.
Largest NO holders
No holders found.
Market FAQ
This market will close for trading on January 1, 2030 at 01:00 AM.
It will be resolved using these rules: The market resolves to YES if at least one CRISPR therapy is approved and shows long-term curative results for a major genetic disease by Dec 31, 2029, per FDA, EMA, or peer-reviewed studies. Resolves to NO otherwise.
This is a public market, so anyone on KrowdCall can view it and participate before trading closes.
This market belongs to the Science category.
The current status of this market is Open.